Dina Muktiarti

Dina Muktiarti

Auto-generated profile, based on publicly available information

Dina Muktiarti

Simulation-Based Medical Education and Research Center Cluster, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Central Jakarta, Jakarta, 10430

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Pediatric Gastroenterology, Hepatology & Nutrition
Verified
Journal Article
Open access
RKRisma K. Kaban
Risma K. Kaban
WAWardhana
Wardhana
BHBadriul Hegar
Badriul Hegar
RRRinawati Rohsiswatmo
Rinawati Rohsiswatmo
SHSetyo Handryastuti
Setyo Handryastuti
Yvan VandenplasYvan Vandenplas
Yvan Vandenplas
Feeding tolerance is extremely important in preterm infants. This study aimed to evaluate whether preterm infants receiving Lactobacillus reuteri DSM 17938 would develop fewer symptoms of feeding intolerance. Secondary outcomes were duration of parenteral nutrition, time to reach full feeding, length of hospital stay, sepsis, necrotizing enterocolitis (NEC), diarrhea, and mortality. This double-blind randomized controlled trial of L. reuteri DSM 17938 versus placebo included 94 neonates with a gestational age of 28-34 weeks and birth weight of 1,000-1,800 g. Feeding intolerance (vomiting and/or distension) was less common in the probiotic group than in the placebo group (8.5% vs. 25.5%; relative risk, 0.33; 95% confidence interval, 0.12-0.96; p=0.03). No significant intergroup differences were found in proven sepsis, time to reach full feeding, length of hospital stay, or diarrhea. The prevalence of NEC (stages 2 and 3) was 6.4% in the placebo group vs. 0% in the probiotic group (relative risk, 1.07; 95% confidence interval, 0.99-1.15; p=0.24). Mortality rates were 2.1% in the probiotic group and 8.5% in the placebo group, p=0.36). The administration of L. reuteri DSM 17938 to preterm infants was safe and significantly reduced feeding intolerance. No significant differences were found in any other secondary outcomes.


13 July 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
CCChee Mun Chan
Chee Mun Chan
ALAmir Hamzah Abdul Latiff
Amir Hamzah Abdul Latiff
LNLokman Mohd Noh
Lokman Mohd Noh
IIIntan Hakimah Ismail
Intan Hakimah Ismail
IHIntan Juliana Abd Hamid
Intan Juliana Abd Hamid
Adli AliAdli Ali
Adli Ali
Introduction: With increased diagnostic capabilities and treatment modalities in the field of primary immunodeficiencies (PID), many pediatric patients survive beyond childhood and experience a change of care to the adult-oriented healthcare system. Unfortunately, the transition pathways for PID are less clearly defined, resulting in deterioration of quality of care in adulthood. Hence, this is the first regional study to address PID clinicians’ opinions on practices and challenges of transition care in 7 Southeast Asia (SEA) countries.Methods: We adopted a cross-sectional study design through an online survey platform to enquire opinions of transition practices from expert representatives in 7 SEA countries.Results: Regionally, 3 out 7 countries reported having no practice of transition care. Among cited challenges were reluctant adaptation by patients and caregivers to unfamiliarized adult healthcare systems, inadequate ratio of adult immunologists to patients and lack of facilities for transfer.Discussion and conclusion: Our study provides evidence to advocate policy makers on the importance of standardized integration of transition practice towards betterment of transiting PID patients into adulthood.

1 March 2021 in Access Microbiology
Verified
Journal Article
Open access
DMDina Muktiarti
Dina Muktiarti
MKMiftahuddin Majid Khoeri
Miftahuddin Majid Khoeri
WTWisnu Tafroji
Wisnu Tafroji
LWLia Waslia
Lia Waslia
DSDodi Safari
Dodi Safari
The aim of this prospective study was to investigate the serotypes and antibiotic susceptibility of S. pneumoniae carried by children infected with HIV before and after vaccination with the seven-valent pneumococcal conjugate vaccine in Jakarta, Indonesia in 2013. We collected nasopharyngeal swab specimens from 52 children pre-vaccination and 6 months post-vaccination. Serotyping was performed by conventional multiplex polymerase chain reaction and Quellung reaction. The antibiotic susceptibility profile was obtained by disc diffusion. We determined that 27 (52%) and 24 (46%) of the 52 children carried S. pneumoniae during pre- and post-vaccination periods, respectively with the majority of the isolates being non-vaccine type strains (85% pre-vaccination and 75% post-vaccination). Serotypes 34, 6C, and 16F (two strains each) were the most commonly identified serotypes at pre-vaccination. Serotypes 23A (three strains) and 19F (two strains) were the most commonly identified serotypes post-vaccination. In general, isolates were most commonly susceptible to chloramphenicol (88%) and clindamycin (88%), followed by erythromycin (84%), trimethoprim-sulphamethoxazole (69%), tetracycline (61%), and penicillin (59%). In conclusion, serotypes of S. pneumoniae isolated from the nasopharynges of children infected with HIV varied and were more likely to be non-vaccine type strains both before and after vaccination.

13 May 2025 in Journal of Human Immunity
Verified
Journal Article
Open access
MYMotoi Yamashita
Motoi Yamashita
YAYunfei An
Yunfei An
DBDharmagat Bhattarai
Dharmagat Bhattarai
VEVicky Wee Eng-Binas
Vicky Wee Eng-Binas
SHSuravat Homvises
Suravat Homvises
HKHirokazu Kanegane
Hirokazu Kanegane
Surveys of healthcare infrastructure for inborn errors of immunity across the Asia-Pacific region reveal significant diagnostic and therapeutic disparities. These data provide a framework for regional policy improvements and highlight the need for equitable resource distribution.

1 January 2025 in Clinical and Experimental Vaccine Research
Verified
Journal Article
Open access
PDF file
WPWisiva Tofriska Paramaiswari
Wisiva Tofriska Paramaiswari
DMDina Muktiarti
Dina Muktiarti
DSDodi Safari
Dodi Safari
RARizqi Amalia
Rizqi Amalia
MPMelati Padma
Melati Padma
ASAmin Soebandrio
Amin Soebandrio
Paramaiswari WT, et al. Clin Exp Vaccine Res. 2025 Mar;14:e19. https://doi.org/10.7774/cevr.2025.14.e19